ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.125,39
0,00%
S&P 500
5.868,55
-0,22%
US Dollar vs BRL
6,1965
0,72%
Bitcoin
96.549,53
-0,36%
Brent Oil
75,695
-0,21%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Scholar Rock Holdings Corporation (SRRK)

  7. Scholar Rock Holdings Corporation (SRRK) Notícias

SRRK

Scholar Rock (SRRK)

Scholar Rock Holdings Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRRK
DataHoraFonteTítuloCódigoCompanhia
02/01/202510:00Business WireScholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
13/12/202418:15Business WireScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRRKScholar Rock Holdings Corporation
26/11/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
12/11/202409:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRRKScholar Rock Holdings Corporation
12/11/202409:00Business WireScholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
04/11/202410:00Business WireScholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with MetforminNASDAQ:SRRKScholar Rock Holdings Corporation
01/11/202409:00Business WireScholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024NASDAQ:SRRKScholar Rock Holdings Corporation
31/10/202417:00Business WireScholar Rock to Participate in Upcoming Investor ConferencesNASDAQ:SRRKScholar Rock Holdings Corporation
31/10/202409:00Business WireScholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
22/10/202409:00Business WireScholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public OfferingNASDAQ:SRRKScholar Rock Holdings Corporation
10/10/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRRKScholar Rock Holdings Corporation
09/10/202417:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SRRKScholar Rock Holdings Corporation
09/10/202400:08Business WireScholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:SRRKScholar Rock Holdings Corporation
07/10/202417:09Business WireScholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:SRRKScholar Rock Holdings Corporation
07/10/202408:00Business WireScholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)NASDAQ:SRRKScholar Rock Holdings Corporation
10/09/202409:00Business WireScholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
04/09/202409:00Business WireScholar Rock Appoints Beth Shafer, Ph.D., to Chief Business OfficerNASDAQ:SRRKScholar Rock Holdings Corporation
08/08/202408:00Business WireScholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
29/07/202420:27Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SRRKScholar Rock Holdings Corporation
23/07/202409:00Business WireScholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024NASDAQ:SRRKScholar Rock Holdings Corporation
24/06/202408:00Business WireScholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist WithdrawalNASDAQ:SRRKScholar Rock Holdings Corporation
03/06/202417:00Business WireScholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
28/05/202409:00Business WireScholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
22/05/202408:00Business WireScholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in ObesityNASDAQ:SRRKScholar Rock Holdings Corporation
14/05/202409:00Business WireScholar Rock to Host Investor Day on May 22, 2024NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202408:00Business WireScholar Rock Reports First Quarter 2024 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
19/03/202408:00Business WireScholar Rock Reports Full Year 2023 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202418:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRRKScholar Rock Holdings Corporation
15/02/202410:00Business WireScholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific OfficerNASDAQ:SRRKScholar Rock Holdings Corporation
06/02/202410:00Business WireScholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss ManagementNASDAQ:SRRKScholar Rock Holdings Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRRK

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
AMER3
Americanas ON
BOV
PRIO3
PETRORIO ON
BOV
FICT3
Fictor Alimentos ON
BOV
RCSL4
RECRUSUL PN
BOV
UNIP6
UNIPAR PNB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados